PuSH - Publication Server of Helmholtz Zentrum München

Size and surface charge of gold nanoparticles determine absorption across intestinal barriers and accumulation in secondary target organs after oral administration.

Nanotox. 6, 36-46 (2012)
DOI PMC
Open Access Green as soon as Postprint is submitted to ZB.
It is of urgent need to identify the exact physico-chemical characteristics, which allow maximum uptake and accumulation in secondary target organs of nanoparticulate drug delivery systems after oral ingestion. We administered radio labelled gold nanoparticles in different sizes (1.4 - 200nm) with negative surface charge and 2.8nm nanoparticles with opposite surface charges by intra-oesophageal instillation into healthy adult female rats. The quantitative amount of the particles in organs, tissues and excrements was measured after 24 hours by gamma-spectroscopy. The highest accumulation in secondary organs was mostly found for 1.4nm particles; the negatively charged particles were accumulated mostly more than positively charged particles. Importantly, 18nm particles show a higher accumulation in brain and heart compared to other sized particles. No general rule accumulation can be made so far. Therefore, specialised drug delivery systems via the oral route have to be individually designed, depending on the respective target organ.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
3.880
1.057
225
279
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Scientific Article
Keywords Gold NP; Gavage; Absorption; Gastro-intestinal tract; In vivo biodistribution
Language english
Publication Year 2012
Prepublished in Year 2011
HGF-reported in Year 2011
ISSN (print) / ISBN 1743-5390
e-ISSN 1743-5404
Journal Nanotoxicology
Quellenangaben Volume: 6, Issue: 1, Pages: 36-46 Article Number: , Supplement: ,
Publisher Informa Healthcare
Publishing Place London
Reviewing status Peer reviewed
PSP Element(s) G-505000-002
PubMed ID 21309618
Scopus ID 83955165727
Erfassungsdatum 2011-05-04